Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WA › Spokane › NPI 1225289895
Hospital

Providence Health & Services - Washington

Providence Health & Services - Washington was paid $43.26M by Medicaid between Jan 2018 and Dec 2024, across 320 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 20% of everything it billed.

33Billing provider infoPROVIDENCE HEALTH & SERVICES - WASHINGTON
SPOKANE, WA 99208
33aNPI1225289895assigned 10/01/2008
28Total paid$43.26M
24GClaims1,298,865
24DCodes billed320
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Washington

Rank by total paid#15 of 49
Median peer was paid$20.06M
This provider vs. median2.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018210,940$7.16M
2019219,591$8.04M
2020197,848$6.77M
2021206,461$7.20M
2022183,953$5.99M
2023155,264$4.41M
2024incomplete124,808$3.70M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
96361 Intravenous infusion, hydration; each additional hour 20% 29,668 25,974 $8.76M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 11% 48,487 45,666 $4.72M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 7.4% 47,401 44,004 $3.21M
S9480 Intensive outpatient psychiatric services, per diem 6.9% 5,519 849 $2.99M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.7% 31,115 29,285 $2.02M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 4.5% 26,013 12,985 $1.96M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.2% 10,692 10,359 $1.81M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3.6% 14,890 10,789 $1.57M
J2323 Injection, natalizumab, 1 mg 3.2% 1,114 1,010 $1.37M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2.9% 4,446 4,326 $1.25M
70450 Computed tomography, head or brain; without contrast material 2.4% 8,001 7,681 $1.05M
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 2.2% 2,514 2,437 $961K
308 more codes
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2.1% 8,695 $928K
95810 Polysomnography; sleep staging with 4 or more additional parameters 2.0% 1,519 $851K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.7% 9,831 $719K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.5% 8,533 $656K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.4% 3,800 $620K
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.4% 2,690 $614K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.3% 3,503 $581K
71275 Computed tomographic angiography, chest, with contrast material 1.0% 3,139 $452K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 3,439 $320K
80053 Comprehensive metabolic panel <1% 65,094 $305K
95806 <1% 717 $292K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 2,406 $280K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 3,178 $267K
12001 <1% 1,128 $229K
70496 <1% 1,522 $228K
10061 <1% 1,106 $226K
93971 <1% 2,628 $219K
70551 Magnetic resonance imaging, brain; without contrast material <1% 1,331 $213K
95782 <1% 301 $209K
J2350 Injection, ocrelizumab, 1 mg <1% 30 $185K
59025 Fetal non-stress test <1% 1,182 $184K
96415 <1% 885 $167K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 457 $166K
87631 <1% 3,711 $163K
76830 Ultrasound, transvaginal <1% 1,870 $142K
G0249 Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests <1% 4,852 $123K
12011 <1% 383 $95K
93017 <1% 970 $89K
10060 <1% 429 $86K
47562 <1% 37 $81K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 260 $74K
12002 <1% 357 $71K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 2,227 $70K
84484 <1% 15,002 $69K
62323 <1% 376 $67K
76801 <1% 922 $63K
27447 <1% 12 $57K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 7,651 $52K
87040 <1% 8,449 $51K
43248 <1% 112 $50K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 4,997 $48K
76937 <1% 656 $48K
95800 <1% 474 $47K
93975 <1% 1,114 $45K
80048 Basic metabolic panel (calcium, ionized) <1% 9,021 $44K
G0378 Hospital observation service, per hour <1% 5,294 $41K
84145 <1% 4,760 $37K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,308 $36K
70498 <1% 1,314 $35K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 403 $33K
90715 <1% 1,921 $33K
95811 <1% 80 $32K
83605 <1% 6,390 $32K
70486 <1% 1,307 $29K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 3,112 $29K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,070 $28K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 64,879 $26K
83880 <1% 4,781 $25K
96367 <1% 1,429 $25K
85379 <1% 4,689 $24K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 5,048 $24K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,254 $23K
64483 <1% 42 $22K
36415 Collection of venous blood by venipuncture <1% 17,475 $21K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,707 $21K
72125 Computed tomography, cervical spine; without contrast material <1% 2,979 $19K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 23,408 $18K
80050 General health panel <1% 3,254 $17K
76770 <1% 177 $16K
97802 <1% 216 $14K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 662 $13K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,674 $10K
70544 <1% 127 $10K
85027 <1% 11,633 $10K
87641 <1% 1,072 $10K
93970 <1% 110 $10K
84443 Thyroid stimulating hormone (TSH) <1% 6,117 $10K
86140 <1% 5,799 $10K
94060 <1% 247 $10K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 35,152 $10K
83735 <1% 8,990 $9K
71046 Radiologic examination, chest; 2 views <1% 10,972 $9K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 299 $9K
P9045 Infusion, albumin (human), 5%, 250 ml <1% 36 $9K
36430 <1% 142 $8K
71045 Radiologic examination, chest; single view <1% 10,349 $7K
88307 <1% 509 $7K
29125 <1% 31 $7K
97803 <1% 193 $7K
96375 Therapeutic injection; each additional sequential IV push <1% 30,180 $6K
97161 <1% 206 $6K
70491 <1% 68 $5K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 1,985 $5K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 473 $5K
64415 <1% 47 $5K
80306 <1% 8,591 $5K
86780 <1% 388 $4K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 11,088 $4K
97597 <1% 91 $4K
85652 <1% 1,607 $4K
76870 <1% 52 $4K
94729 <1% 217 $4K
43235 <1% 13 $4K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 525 $4K
82728 <1% 731 $4K
80143 <1% 1,057 $4K
85610 <1% 28,911 $4K
81001 <1% 24,778 $4K
82962 <1% 22,471 $3K
87581 <1% 473 $3K
87486 <1% 472 $3K
84100 <1% 2,089 $3K
84439 <1% 1,478 $3K
80061 Lipid panel <1% 908 $3K
85007 <1% 1,049 $3K
P9016 Red blood cells, leukocytes reduced, each unit <1% 12 $3K
94726 <1% 162 $3K
Q0247 Injection, sotrovimab, 500 mg <1% 12 $3K
45381 <1% 69 $3K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 12 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 34,708 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 8,326 $2K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring <1% 12 $2K
83690 <1% 19,710 $2K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 14 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 17,070 $2K
80179 <1% 1,015 $2K
90686 <1% 239 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,572 $2K
73630 <1% 2,079 $2K
73610 <1% 2,182 $2K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 600 $2K
96376 <1% 10,362 $2K
97162 <1% 97 $2K
84702 <1% 2,294 $2K
72100 <1% 1,539 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 20,381 $2K
74174 <1% 13 $2K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,513 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 711 $2K
73030 <1% 2,049 $2K
86850 <1% 2,112 $2K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 991 $2K
74018 <1% 1,001 $1K
83550 <1% 431 $1K
83540 <1% 608 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 20,226 $1K
73130 <1% 1,882 $1K
81025 <1% 19,333 $1K
73502 <1% 1,212 $1K
86901 <1% 2,204 $1K
74019 <1% 614 $1K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 15,301 $1K
81003 <1% 18,466 $1K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,253 $1K
87070 <1% 1,830 $1K
J2704 Injection, propofol, 10 mg <1% 15,316 $944.89
82077 <1% 5,999 $926.34
87075 <1% 1,506 $921.43
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 12 $892.14
73560 <1% 776 $891.23
J1815 Injection, insulin, per 5 units <1% 3,914 $882.84
86900 <1% 2,140 $868.85
82550 <1% 1,570 $855.23
73562 <1% 1,122 $847.03
J7030 Infusion, normal saline solution , 1000 cc <1% 29,877 $824.72
87205 <1% 2,091 $812.95
J3490 Unclassified drugs <1% 1,327 $796.10
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 14,850 $783.54
82570 <1% 571 $782.04
86923 <1% 74 $778.89
73140 <1% 590 $675.64
80069 <1% 194 $662.93
73590 <1% 673 $659.36
82805 <1% 1,626 $653.98
73110 <1% 1,238 $649.12
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 9,754 $598.82
89051 <1% 84 $594.23
87077 <1% 2,238 $565.31
87186 <1% 3,316 $555.34
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 7,544 $522.47
J2270 Injection, morphine sulfate, up to 10 mg <1% 6,282 $505.29
85730 <1% 3,105 $486.94
84703 <1% 1,465 $483.53
87088 <1% 2,117 $479.01
81002 <1% 1,511 $445.82
84156 <1% 271 $413.40
73080 <1% 175 $407.71
71101 <1% 678 $383.32
J7050 Infusion, normal saline solution, 250 cc <1% 11,510 $382.44
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 3,006 $373.05
82607 <1% 80 $367.36
87420 <1% 21 $365.80
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 7,065 $351.10
87634 <1% 410 $339.13
73564 <1% 270 $312.42
A9270 Non-covered item or service <1% 11,784 $303.01
87400 <1% 28 $281.92
73090 <1% 328 $280.82
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 6,931 $276.70
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 4,015 $248.56
J3480 Injection, potassium chloride, per 2 meq <1% 1,204 $235.18
87210 <1% 936 $229.79
88342 <1% 1,295 $207.03
J7120 Ringers lactate infusion, up to 1000 cc <1% 8,761 $170.48
84550 <1% 283 $164.32
82784 <1% 72 $163.49
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 3,745 $145.80
C1769 Guide wire <1% 1,384 $141.59
90656 <1% 15 $133.62
84112 <1% 41 $133.48
87340 <1% 50 $130.69
87081 <1% 288 $127.03
85018 <1% 258 $119.04
87147 <1% 315 $116.84
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,651 $114.49
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,937 $104.07
86803 <1% 29 $102.87
82105 <1% 25 $102.67
73660 <1% 28 $94.20
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,756 $90.87
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 1,084 $81.12
80164 <1% 15 $79.97
85014 <1% 149 $76.35
J0690 Injection, cefazolin sodium, 500 mg <1% 6,983 $72.39
82945 <1% 27 $71.54
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 285 $70.22
82565 <1% 39 $70.00
J2060 Injection, lorazepam, 2 mg <1% 4,372 $68.96
86364 <1% 12 $65.08
88304 <1% 948 $64.20
84157 <1% 31 $52.75
80076 <1% 15 $50.69
99152 <1% 56 $50.43
87493 <1% 39 $46.74
73070 <1% 30 $40.53
82746 <1% 14 $36.57
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 2,495 $32.29
82010 <1% 341 $31.33
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,757 $30.59
82803 <1% 60 $29.31
86592 <1% 29 $27.86
A9585 Injection, gadobutrol, 0.1 ml <1% 177 $27.20
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 2,913 $22.32
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 1,846 $22.17
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 36 $17.84
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 119 $17.51
J2550 Injection, promethazine hcl, up to 50 mg <1% 4,328 $11.87
J8540 Dexamethasone, oral, 0.25 mg <1% 1,110 $11.40
J1040 Injection, methylprednisolone acetate, 80 mg <1% 716 $10.62
J0780 Injection, prochlorperazine, up to 10 mg <1% 1,449 $10.34
36600 <1% 26 $9.15
99153 Mod sedat endo service >5yrs <1% 300 $8.01
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 4,811 $5.20
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 745 $4.07
36591 <1% 29 $3.93
J1630 Injection, haloperidol, up to 5 mg <1% 1,289 $1.98
J1940 Injection, furosemide, up to 20 mg <1% 312 $1.74
J1644 Injection, heparin sodium, per 1000 units <1% 2,172 $0.08
C9113 Injection, pantoprazole sodium, per vial <1% 1,813 $0.04
J3370 Injection, vancomycin hcl, 500 mg 0% 2,288 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 15,935 $0.00
J0692 Injection, cefepime hydrochloride, 500 mg 0% 379 $0.00
J1245 Injection, dipyridamole, per 10 mg 0% 130 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 143 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 246 $0.00
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm 0% 541 $0.00
87806 0% 148 $0.00
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg 0% 95 $0.00
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) 0% 716 $0.00
C1776 Joint device (implantable) 0% 174 $0.00
96417 0% 123 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 0% 45 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 305 $0.00
C1758 Catheter, ureteral 0% 42 $0.00
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg 0% 81 $0.00
J3415 Injection, pyridoxine hcl, 100 mg 0% 67 $0.00
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring 0% 60 $0.00
29824 0% 13 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 207 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 15 $0.00
72050 0% 12 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 14 $0.00
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml 0% 903 $0.00
J3411 Injection, thiamine hcl, 100 mg 0% 734 $0.00
J1790 Injection, droperidol, up to 5 mg 0% 179 $0.00
74420 0% 39 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 603 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 584 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 850 $0.00
C1726 Catheter, balloon dilatation, non-vascular 0% 24 $0.00
J1836 Injection, metronidazole, 10 mg 0% 192 $0.00
J0456 Injection, azithromycin, 500 mg 0% 44 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 17 $0.00
S2900 Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) 0% 12 $0.00
C1781 Mesh (implantable) 0% 57 $0.00
C1889 Implantable/insertable device, not otherwise classified 0% 298 $0.00
J0280 Injection, aminophyllin, up to 250 mg 0% 143 $0.00
89060 0% 14 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 108 $0.00
96368 0% 122 $0.00
73552 0% 13 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 56 $0.00
C2617 Stent, non-coronary, temporary, without delivery system 0% 41 $0.00
86308 0% 14 $0.00
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries 0% 27 $0.00
J7999 Compounded drug, not otherwise classified 0% 68 $0.00
88341 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialANDERSON, DONALD (ASSISTANT SECREATRY FOR ENROLLMENT)
Same official

Other billing entities under ANDERSON, DONALD

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.